A Neonate with a Diagnosis of Pontocerebellar Hypoplasia Type 6 Treated with Biotin and Developed Biotin Interference with Laboratory Thyroid Function Tests

Motomichi Nagafuji; Daisuke Hitaka; Atsushi Iwabuchi; Yayoi Miyazono; Hidetoshi Takada

doi:10.12659/AJCR.934417

21 December 2021 : Case report Japan

A Neonate with a Diagnosis of Pontocerebellar Hypoplasia Type 6 Treated with Biotin and Developed Biotin Interference with Laboratory Thyroid Function Tests

Unusual clinical course

Motomichi Nagafuji^1ABCEF*, Daisuke Hitaka^1EF, Atsushi Iwabuchi^12DEF, Yayoi Miyazono

^12EF, Hidetoshi Takada^12DEF

DOI: 10.12659/AJCR.934417

Am J Case Rep 2021; 22:e934417

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. Clinical course of the infant. The line graphs show the values of fT3 (black), fT4 (dotted line), TSH (double dotted line), and TRAb (point). MMI – methimazole; FFP – fresh frozen plasma; fT3 – free triiodothyronine; fT4 – free thyroxine; TSH – thyroid-stimulating hormone; TRAb – thyroid-stimulating hormone receptor antibody.

Back to the Article

A Neonate with a Diagnosis of Pontocerebellar Hypoplasia Type 6 Treated with Biotin and Developed Biotin Interference with Laboratory Thyroid Function Tests

Your Privacy